Hudson Bay Capital Management »

Akero Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 339k 47.48
2025-06-30 $21M 387k 53.36
2025-03-31 $12M 302k 40.48
2024-12-31 $7.2M 260k 27.82
2024-09-30 $4.4M 155k 28.69

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Netflix Call Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Advanced Micro Devices Put Option (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Strategy Cl A New Call Option (MSTR)
Robinhood Mkts Com Cl A Call Option (HOOD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Dollar Tree Call Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
Rtw Investments
Vanguard Group
Wellington Management Company
Deep Track Capital
venBio Select Advisor
State Street Corporation
Bellevue Group
Point72 Asset Management
Alkeon Capital Management
Geode Capital Management
Alliancebernstein
Marshall Wace

View all funds holding Akero Therapeutics